Contact l Sitemap

home industries issues reasearch weblog press

Home  » Industries » Pharmaceuticals

News Articles : Displaying 41-60 of 161


INDIA: Setback for Novartis in India Over Drug Patent
by Amelia GentlemanThe New York Times
August 7th, 2007
Indian companies will be free to continue making less expensive generic drugs, much of which flow to the developing world, after a court rejected a challenge to the patent law on Monday.

US: Lawmaker Calls for Registry of Drug Firms Paying Doctors
by Gardiner HarrisNew York Times
August 4th, 2007
An influential Republican senator says he will propose legislation requiring drug makers to disclose the payments they make to doctors for services like consulting, lectures and attendance at seminars.

US: FDA Panel to Review Avandia
by Jennifer Corbett DoorenThe Wall Street Journal
July 26th, 2007
The Food and Drug Administration will ask a panel of outside medical experts Monday whether it thinks GlaxoSmithKline PLC's diabetes drug Avandia should remain on the U.S. market.

US: Tax Break Used by Drug Makers Failed to Add Jobs
by Alex BerensonThe New York Times
July 24th, 2007
Two years ago, when companies received a big tax break to bring home their offshore profits, the president and Congress justified it as a one-time tax amnesty that would create American jobs. Drug makers were the biggest beneficiaries of the amnesty program, repatriating about $100 billion in foreign profits and paying only minimal taxes. But the companies did not create many jobs in return. Instead, since 2005 the American drug industry has laid off tens of thousands of workers in thi

US: Drug Safety Critic Hurls Darts From the Inside
by Stephanie SaulNew York Times
July 23rd, 2007
An activist doctor emerges as the nation's unoffical ariter of drug safety by digging deep into companies' clinical data. At the same time, he presides over industry-financeed research worth millions of dollars.

NIGERIA: Nigeria Adds Fraud Charge Against Pfizer in Civil Lawsuit
by Associated PressWall Street Journal
July 20th, 2007
Nigerian government lawyers added a tougher fraud charge in their $7 billion civil lawsuit against drug maker Pfizer Friday.

US: 3 Executives Spared Prison in OxyContin Case
by Barry MeierThe New York Times
July 20th, 2007
After hearing testimony from parents of young adults who died from overdoses involving the painkiller OxyContin, a federal judge Friday sentenced three top executives of the company that makes the narcotic to three years' probation and 400 hours each of community service in drug treatment programs.

NIGERIA: Pfizer wins early Nigeria battle
BBC News
June 26th, 2007
A Nigerian court has refused to allow more cases to be added to a lawsuit against a pharmaceutical giant accused of improper drugs trials on children.

US: Bristol-Myers to Pay Fine
Agence France Presse
May 31st, 2007
Bristol-Myers Squibb has agreed to plead guilty and pay a $1 million criminal fine for lying to the government about a patent deal on its blood-thinning drug Plavix, officials said Wednesday. The Justice Department said in a statement that the company’s actions had threatened to reduce competition for the drug, one of the best-selling prescription medications worldwide.

NIGERIA: Pfizer Faces Criminal Charges in Nigeria
by Joe StephensWashington Post
May 30th, 2007
Officials in Nigeria have brought criminal charges against pharmaceutical giant Pfizer for the company's alleged role in the deaths of children who received an unapproved drug during a meningitis epidemic.

THAILAND: Holding Big Pharma's feet to the fire
by Marwaan Macan-MarkarInter Press Service
May 17th, 2007
For nearly a week, the advertising pages of Thai- and English-language dailies have been the stage for debates on Thailand's decision to break patents on anti-AIDS drugs in the interest of public health. A lobby championing the cause of the powerful pharmaceutical companies ran full-page spreads in the morning newspapers with an eye-catching warning in large, bold text, which said: "The Wrong Prescription for Thailand".

BRAZIL: Brazil to break Aids drug patent
BBC
May 4th, 2007
Brazil's president has authorised the country to bypass the patent on an Aids drug manufactured by Merck, a US pharmaceutical giant.

US: Doctors’ Ties to Drug Makers Are Put on Close View
by Gardiner HarrisThe New York Times
March 21st, 2007
Dr. Allan Collins may be the most influential kidney specialist in the country. He is president of the National Kidney Foundation and director of a government-financed research center on kidney disease.

US: BP/UC Deal Raises Concerns
by Richard BrennemanBerkeley Daily Planet
March 2nd, 2007
The proposed agreement between one of the world’s largest oil companies, BP (formerly British Petroleum) and UC Berkeley, Lawrence Berkeley National Laboratory and the University of Illinois has ignited a firestorm that promises to burn long and hot.

US: Corporate Profits Take an Offshore Vacation
by Lucy KomisarInter Press Service
February 23rd, 2007
Last week, Merck, the pharmaceutical multinational, announced that it will pay 2.3 billion dollars in back taxes, interest and penalties in one of the largest settlements for tax evasion the U.S. Internal Revenue Service (IRS) has ever imposed.

SOUTH AFRICA: MCC stalls new Aids drugs
by Belinda BeresfordMail & Guardian Online
February 3rd, 2007
South Africans have been denied the “biggest advance” in antiretroviral therapy over the last few years because of a lack of urgency in the drug registration process in South Africa, according to the Treatment Action Campaign.

INDIA: Novartis challenges India's patent law
by Matthew AllenSwiss Info
January 29th, 2007
A court case brought by Swiss drugs giant Novartis in India could define how the industry distributes discount medicine to the developing world while maintaining profits.

ASIA: Asian Govts Push Generic Drugs
by Marwaan Macan-MarkarInter Press Service
December 18th, 2006
In moves that are winning them praise, two South-east Asian governments -- in Thailand and the Philippines -- appear determined to push ahead with plans to provide cheaper generic drugs even if they incur the wrath of pharmaceutical giants.

US: Corporation wants to drill on Mt. Taylor
by Zsombor PeterThe Gallup Independent
December 7th, 2006
After drilling six exploratory holes by Mt. Taylor earlier this year in search of uranium, the Western Energy Development Corporation is asking for state and federal permission to drill 47 more.

US: Pfizer Drug Dealt Blow in Testing
by Alex BerensonThe New York Times
November 1st, 2006
Pfizer said yesterday that clinical trials of torcetrapib — a heart medication that is the most important drug in the company’s pipeline — confirmed that it raises blood pressure, a potentially serious side effect.

Displaying 41-60 of 161  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List »